Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06990048 · ClinicalTrials.gov registry record
The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System
A clinical trial of Abdominal Aortic Aneurysm, sponsored by Endologix.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT06990048 is a study of Abdominal Aortic Aneurysm that is actively recruiting participants, run by Endologix. The registered enrollment target is 2,000 participants, above the 329-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (508% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06990048, a study of Abdominal Aortic Aneurysm, is actively recruiting participants, sponsored by Endologix.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational, retrospective, multicenter study to evaluate the performance of the AFX2 System using real world evidence from VQI-VISION.
Conditions Studied
Interventions
- DEVICE AFX2 System
Study Locations (1)
New Hampshire
- The Dartmouth Institute - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2023-09-21 |
| Est. Completion | 2027-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06990048
The ClinicalTrials.gov registry entry for NCT06990048 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 329-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (508% higher). The listed sponsor is Endologix, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which AFX2 System is the first listed.
NCT06990048 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.
Frequently Asked Questions
What is clinical trial NCT06990048 about?
NCT06990048 is a clinical study titled "The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System". This is an observational, retrospective, multicenter study to evaluate the performance of the AFX2 System using real world evidence from VQI-VISION.
What is the current status of trial NCT06990048?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2023-09-21. Estimated completion is 2027-05.
What conditions does trial NCT06990048 study?
This clinical trial studies the following conditions: Abdominal Aortic Aneurysm.
What interventions are being tested in trial NCT06990048?
The interventions under investigation include: AFX2 System (DEVICE).
Who is sponsoring clinical trial NCT06990048?
This trial is sponsored by Endologix, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06990048 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Terumo Aortic Global Endovascular Registry
RECRUITING
-
Limiting AAA With Metformin (LIMIT) Trial
RECRUITING · Phase 2
-
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
RECRUITING · NA
-
Nectero EAST System Clinical Study
RECRUITING · Phase 2
-
PET Imaging of MMP Activation in AAA: Clinical Component
RECRUITING · Early Phase 1
-
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.